The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
23/12/2016 - 5 minutes
Eli Lilly
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s…
19/12/2016 - 7 minutes
Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
07/11/2016 - 2 minutes
Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
04/04/2016 - 5 minutes
A Relief for Migraines at last? The Biotech race for the Ultimate Cure
A Migraine is more than just a headache; it is a neurological disorder affecting a…
17/03/2016 - 4 minutes
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by…
25/01/2016 - 3 minutes
This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve
Human insulin produced in Bacteria is already a miracle for Diabetes...but sometimes, it’s not as…
09/11/2015 - 3 minutes
Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private…
16/07/2015 - 3 minutes
Lilly Cooperates with Immunocore to Fight Skin Cancer
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based…
03/07/2015 - 2 minutes
Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?
Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a…
01/07/2015 - 2 minutes
AstraZeneca and Eli Lilly Combine their Innovative Drugs for Cancer Treatment
The big pharma companies Eli Lilly and AstraZeneca will combine two of their cancer drugs…
31/05/2015 - 2 minutes
Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies
Using immunotherapy to treat cancer is one of the hottest trends in healthcare research right…
14/05/2015 - 2 minutes
